Categories - Press Releases
2 posts
0

i2 Pharmaceuticals Acquires Antibody and Protein Engineering Technology Portfolio from Sea Lane Biotechnologiesfeatured

Boulder CO – May 30, 2017 – i2 Pharmaceuticals, Inc., a biopharmaceutical company focused on next generation discovery and development of therapeutics with a focus on personalized cancer treatment, announced the acquisition of all of the antibody and engineered protein technology of Sea Lane Biotechnologies, LLC, Redwood City, California, including several potential product candidates. The Read more

0

i2 Pharmaceuticals Appoints Chief Business Officerfeatured

Boulder CO – April 25, 2017 – i2 Pharmaceuticals, Inc., a biopharmaceutical company focused on next generation discovery and development of therapeutics with a focus on personalized cancer treatment, announced that Mark F. Kubik has joined the company in the role of Chief Business Officer effective February 1, 2017. Mr. Kubik will report to Dr. Read more

Loading...